Medication info
CMG Montelukast Chewable Tablets 5 mg (Montelukast Sodium)

CMG Montelukast Chewable Tablets 5 mg (Montelukast Sodium)

Prescription medicationChewable TabletOral
Ingredient · strength
Montelukast Sodium›5.2mg / 1 tablet
Manufacturer / importer
CMG Pharmaceutical Co., Ltd.
Appearance
Pink chewable tablet with a biconvex round shape.
Packaging
28 tablets (4 PTPs of 7 tablets each)
Approval status
Active

MFDS item code 201905520 · Approved 2019.08.05 · Insurance code 648604340

Summary

Main use
Prevention and treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms
Who takes it
Adults · Children
Adult dose
Take this drug once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the dosing time should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet once daily in the evening. Adults and adolescents aged 15 years and older: Administer 10 mg of montelukast orally once daily.
Child dose
Children aged 6~14 years: Chew 5 mg of montelukast once daily. Administer this drug 1 hour before or 2 hours after a meal. Children aged 2~5 years: Chew 4 mg of montelukast once daily. Administer this drug 1 hour before or 2 hours after a meal.

Ingredients

Manufacturer
CMG Pharmaceutical Co., Ltd.

Efficacy & effects

Prevention and treatment of asthma; relief of seasonal and perennial allergic rhinitis symptoms

  • Asthma
  • symptoms of allergic rhinitis
View approved original text

This medication helps prevent and treat asthma continuously. It is also used to relieve symptoms of seasonal and perennial allergic rhinitis.

How to take

Adult dose

Take this drug once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the dosing time should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet once daily in the evening. Adults and adolescents aged 15 years and older: Administer 10 mg of montelukast orally once daily.

Child dose

Children aged 6~14 years: Chew 5 mg of montelukast once daily. Administer this drug 1 hour before or 2 hours after a meal. Children aged 2~5 years: Chew 4 mg of montelukast once daily. Administer this drug 1 hour before or 2 hours after a meal.

Precautions

This medication is used for the treatment of asthma and allergic rhinitis. During treatment with this medication, significant neuropsychiatric symptoms may occur, so patients and caregivers should closely monitor for changes in mental state such as agitation, anxiety, depression, hallucinations, and suicidal thoughts. If new neuropsychiatric symptoms or behavioral changes occur, discontinue use immediately and consult a physician. This medication contains the artificial sweetener aspartame, so patients with a genetic disorder called phenylketonuria should avoid it and also limit their intake of aspartame. For formulations containing lactose, it should not be administered to patients with genetic issues such as lactose intolerance or galactose intolerance. This medication is not an emergency treatment for acute asthma attacks, so appropriate emergency medications should always be carried and used in the event of acute symptoms. While taking this medication, the dosage of inhaled corticosteroids may be adjusted according to a physician's instructions, but sudden changes are prohibited. It should not be used alone to treat exercise-induced bronchospasm; inhaled beta-agonists should be used in combination as needed. Patients with hypersensitivity to aspirin or nonsteroidal anti-inflammatory drugs should avoid using those medications while taking this product. Rarely, various adverse reactions may occur, including those affecting blood, liver, nervous system, and skin, so if any unusual symptoms arise, consult a physician immediately. Pregnant or breastfeeding women should exercise caution when taking this medication, especially during pregnancy, and should only take it if absolutely necessary. Children and the elderly should also be monitored for safety, especially as the safety and efficacy for children under 6 months of age have not been established. In cases of overdose, there is no specific antidote, and general symptomatic treatment and clinical monitoring are necessary. Keep the medication out of reach of children and avoid transferring it to other containers. This medication should be taken consistently even when asthma symptoms are not present, and if symptoms worsen, consult your physician promptly.

Side effects

  • Anxiety
  • aggressive behavior
  • depression
  • disorientation
  • attention deficit
  • stuttering
  • sleep disorders
  • hallucinations
  • insomnia
  • memory impairment
Show 91 more
  • obsessive-compulsive disorder
  • psychomotor hyperactivity
  • irritability
  • instability
  • forwardness
  • somnambulism
  • suicidal impulses
  • suicidal behavior
  • tics
  • weakness
  • fatigue
  • fever
  • abdominal pain
  • trauma
  • dyspepsia
  • infectious gastroenteritis
  • toothache
  • dizziness
  • headache
  • nasal congestion
  • cough
  • influenza
  • rash
  • increased ALT
  • increased AST
  • pyuria
  • pharyngitis
  • sinusitis
  • nausea
  • diarrhea
  • loss of appetite
  • otalgia
  • viral infection
  • laryngitis
  • (infectious) rhinitis
  • chickenpox
  • gastroenteritis
  • atopic dermatitis
  • acute bronchitis
  • dental infection
  • skin infection
  • myopia
  • rhinorrhea
  • ear pain
  • enteritis
  • eczema
  • urticaria
  • pneumonia
  • dermatitis
  • conjunctivitis
  • upper respiratory tract infection
  • wheezing
  • otitis media
  • tonsillitis
  • drowsiness
  • sensory abnormalities
  • sensory diminution
  • convulsive seizures
  • palpitations
  • epistaxis
  • pulmonary eosinophilia
  • vomiting
  • cholestatic hepatitis
  • hepatocellular injury
  • mixed-type liver damage
  • angioedema
  • bruising
  • erythema multiforme
  • nodular erythema
  • itching
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • arthralgia
  • muscle cramps
  • myalgia
  • nocturia
  • edema
  • increased frequency of bleeding
  • thrombocytopenia
  • hypersensitivity reactions
  • anaphylaxis
  • hepatic eosinophilic infiltration
  • psychomotor agitation
  • systemic eosinophilia
  • Churg-Strauss syndrome
  • vasculitis
  • vasculitic rash
  • worsening pulmonary symptoms
  • cardiac complications
  • neuropathy
  • alopecia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to moisture and light, so it should be stored at room temperature between 1°C and 30°C. It is important to keep it in a tightly sealed container to prevent air exposure.

Appearance and packaging

Appearance

Pink chewable tablet with a biconvex round shape.

Package unit

28 tablets (4 PTPs of 7 tablets each)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.